This could indicate that ZBTB20 is nonfunctional in glioblastoma cells, or alternatively, that it has not yet exerted its regulatory effects on pathways associated with mitochondrial dysfunction after 24 h of treatment. The gene discussed is ZBTB20; the disease is glioblastoma.